EDMONTON, Alberta, Feb. 28 /PRNewswire-FirstCall/ -- Medical Services International Inc (OTC:MSITF) wishes to announce that it will begin supplying the VScan HIV rapid test kit to retail outlets in India. The kits will be supplied from our assembly plant in Amstar India. The distributor for India has indicated that the retail outlets will require up to 700,000 VScan HIV test kits in the first year. In addition to the VScan HIV test kits, the VScan TB test kit is being evaluated for regulatory approval. There are new outbreaks of Tuberculosis (TB) in India and a demand for a rapid TB diagnostic test kit. The VScan TB test kit only detects active TB and gives no false positives. It has been reported by regulatory agencies that of the people infected with the HIV virus over 35% also have TB. Tuberculosis is highly contagious and will cause the death of over 8 million people this year. TB can be effectively treated with early detection. There is a significant need for a rapid diagnostic test kit for detection of TB. Medical Services feels that its VScan TB test kit will fill this demand. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies. DATASOURCE: Medical Services International Inc CONTACT: Robert Talbot of Medical Services International Inc, +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright